RFA for Thyroid Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test the effectiveness of using heat from radio waves to treat small thyroid cancers. It will focus on patients with small papillary thyroid carcinoma and will monitor changes in tumor size and other health indicators after treatment. Radiofrequency ablation (RFA) has been studied as a treatment for small papillary thyroid microcarcinomas, particularly in patients who are ineligible for surgery.
Who Is on the Research Team?
Marius Stan, MD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for adults with a small papillary thyroid carcinoma (less than 1.5 cm) that can be treated without surgery, as decided by their doctor and radiologist. It's not for those with widespread cancer, pregnant women, individuals who have difficult neck anatomy for RFA access, high anesthesia risk due to other illnesses, recent investigational drug use, substance abuse issues, blood clotting disorders or prior neck treatments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo radiofrequency ablation (RFA) therapy for papillary thyroid carcinoma
Follow-up
Participants are monitored for changes in primary tumor volume, lymph node involvement, distant metastasis, and serum thyroid hormone levels
What Are the Treatments Tested in This Trial?
Interventions
- RFA
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor